Enrollment is now complete in the CORAL clinical trial of nalbuphine ER, to be marketed as Haduvio, for IPF patients with ...

CS014 has shown the ability to reverse scarring and ease blood vessel remodeling in a preclinical model of pulmonary arterial ...

Joining the IPF community may not be voluntary, columnist Sam Kirton says, but he's grateful for the fraternity he's found along the way.

Columnist Sam Kirton encourages the PF community to advocate, share their stories, and make their voices heard by legislators.

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

Nerandomilast, an oral treatment being developed by Boehringer Ingelheim, bested a placebo at preserving lung function in adults with progressive pulmonary fibrosis in a Phase 3 study, according to ...

A protein called Runx2 contributes to the abnormal activity of lung cells that drive pulmonary fibrosis, a new study shows, suggesting that inhibiting this protein may be an effective strategy for ...

Living with a rare lung disease such as pulmonary fibrosis (PF) is a daily battle that requires strength and perseverance. Many individuals, me included, face this journey with courage, often in the ...

Winter storm warning. Those three simple words never bothered me much until I was diagnosed with idiopathic pulmonary fibrosis (IPF). Afterward, those words defeated me. They were an indication of ...